# Stellus Capital Investment Corp: overview SCM · NYSE · CIK 1551901 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/scm.md) · [Financials](/companies/scm/financials.md) · [Filings](/companies/scm/filings.md) · [Insiders](/companies/scm/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.59](/filings/0001104659-25-109139.md) | not reported | [0.18](/filings/0001104659-26-058699.md) | [0.36](/filings/0001104659-26-093435.md) | [0.23](/filings/0001104659-25-109139.md) | not reported | [0.06](/filings/0001104659-26-058699.md) | [0.56](/filings/0001104659-26-093435.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.72](/filings/0001558370-24-002368.md) | [0.74](/filings/0001558370-25-002182.md) | [0.80](/filings/0001104659-26-026432.md) | [1.79](/filings/0001104659-26-026432.md) | [0.95](/filings/0001104659-26-026432.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/scm/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $2.4m | 284,746 | | Added +29,267 | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $2.2m | 263,356 | | Reduced −51,436 | | [Muzinich & Co., Inc.](/funds/1618824.md) | 2026-06-30 | $2.1m | 255,026 | | Added +192 | | [RAYMOND JAMES FINANCIAL INC](/funds/720005.md) | 2026-06-30 | $2.1m | 252,821 | | Added +15,222 | | [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $2.0m | 238,329 | | Added +8,794 | | [Sunbelt Securities, Inc.](/funds/1632932.md) | 2026-03-31 | $1.9m | 203,190 | | Not compared | | [Advisors Asset Management, Inc.](/funds/1297376.md) | 2026-06-30 | $1.9m | 220,277 | | Added +27,584 | | [Ethos Financial Group, LLC](/funds/1954242.md) | 2026-06-30 | $1.8m | 217,193 | | Added +19,403 | | [CONDOR CAPITAL MANAGEMENT](/funds/1082491.md) | 2026-06-30 | $1.8m | 211,987 | | Added +5,571 | | [Sumitomo Mitsui Trust Group, Inc.](/funds/1475365.md) | 2026-06-30 | $1.3m | 156,151 | | Unchanged | ## Recent filings [All 443 filings](/companies/scm/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-10 | 20:47 ET | [10-Q](/filings/0001104659-26-093435.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093435 | | 2026-07-29 | 21:05 ET | [8-K](/filings/0001104659-26-088224.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-088224 | | 2026-06-22 | 21:00 ET | [8-K](/filings/0001104659-26-076452.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-076452 | | 2026-06-17 | 11:00 ET | [8-K](/filings/0001104659-26-074850.md) | 5.07 Shareholder vote results | 0001104659-26-074850 | | 2026-05-11 | 20:41 ET | [10-Q](/filings/0001104659-26-058699.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058699 | | 2026-04-16 | 21:15 ET | [DEF 14A](/filings/0001104659-26-044452.md) | Proxy statement, period 2026-06-16 | 0001104659-26-044452 | | 2026-03-11 | 20:49 ET | [10-K](/filings/0001104659-26-026432.md) | Annual report, period 2025-12-31 | 0001104659-26-026432 | | 2026-02-05 | 12:42 ET | [8-K](/filings/0001104659-26-010653.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-010653 | | 2025-11-24 | 21:15 ET | [8-K](/filings/0001104659-25-115422.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-115422 | | 2025-11-10 | 21:08 ET | [10-Q](/filings/0001104659-25-109139.md) | Quarterly report, period 2025-09-30 | 0001104659-25-109139 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-026432.md), filed Mar 11, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1551901 - Tickers: SCM - Exchange: NYSE - SIC code: not reported - State of incorporation: MD - Filer category: Accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.